We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 28

Oklahoma Attorney General's lawsuit against Chinese manufacturer latest in trend of antitrust actions by U.S. states

  • Jones Day
  • -
  • China, USA
  • -
  • March 20 2014

The Oklahoma Attorney General has brought a state law action against a Chinese manufacturer of valves used in the petroleum industry, alleging the

Highlights of the DOJ Deputy Assistant Attorney General Antitrust Division’s keynote address applying the joint DOJPTO Policy Statement at the ITC

  • King & Spalding LLP
  • -
  • USA
  • -
  • March 13 2014

On February 26, 2014, Renata B. Hesse, Deputy Assistant Attorney General Antitrust Division of the U.S. Department of Justice (DOJ), gave a keynote

New York court affirms jury verdict against Chinese manufacturers of vitamin C, awards attorneys' fees to plaintiffs

  • Cadwalader Wickersham & Taft LLP
  • -
  • USA
  • -
  • January 3 2014

In a recently released decision, a federal court in New York has declined to overturn a jury's $153.3 million verdict against vitamin C

Criminal and related antitrust developments in 2012: Canada and the world

  • Fasken Martineau DuMoulin LLP
  • -
  • Australia, Canada, China, European Union, India, Japan, New Zealand, South Korea, United Kingdom, USA
  • -
  • April 2 2013

This article outlines the major global criminal and related antitrust developments in 2012, with a focus on Canada. Three salient realities

Chinese vitamin C producers price-fixing verdict raises questions of comity and conflict with executive branch views

  • Davis Polk & Wardwell LLP
  • -
  • China, USA
  • -
  • March 27 2013

In a case that potentially has important implications for U.S. antitrust enforcement and for U.S. trade relations with the People's Republic of China

Does it ever make sense for foreign companies to “roll the dice” in an antitrust case?

  • Steptoe & Johnson LLP
  • -
  • China, USA
  • -
  • March 27 2013

On March 14, a jury sitting in the US District Court for the Eastern District of New York found that Chinese suppliers of Vitamin C had acted in

Solyndra pursues the Chinese

  • Chadbourne & Parke LLP
  • -
  • USA
  • -
  • November 15 2012

Solyndra, a now-defunct American manufacturer of photovoltaic solar panels, filed an antitrust suit against three Chinese companies Suntech, Trina and Yingli in October alleging the companies conspired to drive Solyndra, and about a dozen other solar panel manufacturers, out of business and thus monopolize the American market

FTC finalizes new rules related to Part 2 (non-adjudicative) investigations and attorney conduct

  • Hogan Lovells
  • -
  • USA
  • -
  • October 31 2012

On 20 September 2012, the US Federal Trade Commission announced final changes to its internal Rules of Practice regarding Part 2 (nonadjudicative) investigations and attorney conduct

New York federal court refuses to dismiss Chinese company from U.S. price-fixing case

  • Cadwalader Wickersham & Taft LLP
  • -
  • USA
  • -
  • August 17 2012

In a decision filed on August 7, 2012, in a federal court in New York, a judge ruled that a Chinese company could not evade jurisdiction of the U.S. courts and must face the prospect of a trial for colluding to fix the price of vitamin C exported from China into the United States

FTC proposes changes to HSR reportability of patent licenses

  • Ropes & Gray LLP
  • -
  • USA
  • -
  • August 14 2012

The Federal Trade Commission has announced proposed rule changes that will impact the reportability of pharmaceutical patent licenses under the Hart-Scott-Rodino Antitrust Improvements Act of 1976